CI&T Inc carries a market capitalization of 497.26M, placing it among publicly traded companies globally. Its enterprise value stands at 3.52B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 497.26M |
| Enterprise Value | 3.52B |
CI&T Inc currently has 128.53M shares outstanding.
| Shares Outstanding | 128.53M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
CI&T Inc trades at a trailing price-to-earnings ratio of 84.38. The price-to-sales ratio is 6.67, and the price-to-book ratio stands at 23.53.
| PE Ratio | 84.38 |
| PS Ratio | 6.67 |
| PB Ratio | 23.53 |
| P/TBV Ratio | -210.80 |
| P/FCF Ratio | 50.01 |
| P/OCF Ratio | 63.56 |
On an enterprise value basis, CI&T Inc trades at an EV/EBITDA multiple of 42.99 and an EV/FCF ratio of 44.55. The EV/Sales ratio of 6.82 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 56.90 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.82 |
| EV / EBITDA | 42.99 |
| EV / EBIT | 56.90 |
| EV / FCF | 44.55 |
CI&T Inc maintains a current ratio of 1.37, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 40.21, indicating elevated leverage, while an interest coverage ratio of 6.23 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.37 |
| Quick Ratio | 1.33 |
| Debt / Equity | 40.21 |
| Debt / EBITDA | 1.57 |
| Interest Coverage | 6.23 |
CI&T Inc posts a return on equity of 32.40 and a return on invested capital of 9.99.
| Return on Equity (ROE) | 32.40 |
| Return on Assets (ROA) | 7.36 |
| Return on Invested Capital (ROIC) | 9.99 |
| Return on Capital Employed (ROCE) | 19.06 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, CI&T Inc has paid 15.12M in income taxes, reflecting an effective tax rate of 27.07.
| Income Tax | 15.12M |
| Effective Tax Rate | 27.07 |
CI&T Inc's stock has declined approximately -36.22112% over the past 52 weeks. The 50-day moving average sits at 4.26, while the 200-day moving average is 4.70.
| Beta (5Y) | N/A |
| 52-Week Price Change | -36.22112% |
| 50-Day Moving Average | 4.26 |
| 200-Day Moving Average | 4.70 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, CI&T Inc generated 515.38M in revenue and converted that into 40.74M in net income, yielding earnings per share of 0.31. EBITDA reached 81.82M, while operating income came in at 61.82M.
| Revenue | 515.38M |
| Gross Profit | 161.86M |
| Operating Income | 61.82M |
| Pretax Income | 55.85M |
| Net Income | 40.74M |
| EBITDA | 81.82M |
| EBIT | 61.82M |
| Earnings Per Share (EPS) | 0.31 |
CI&T Inc holds 48.12M in cash and equivalents against 128.09M in total debt, resulting in a net debt position of 72.76M. Total book value stands at 146.10M, with working capital of 57.13M providing operational flexibility.
| Cash & Cash Equivalents | 48.12M |
| Total Debt | 128.09M |
| Net Debt | 72.76M |
| Equity (Book Value) | 146.10M |
| Book Value Per Share | 1.12 |
| Working Capital | 57.13M |
CI&T Inc produced 54.08M in operating cash flow over the past twelve months. After subtracting -15.28M in capital expenditures, free cash flow totaled 38.80M - equivalent to 0.30 per share.
| Operating Cash Flow | 54.08M |
| Capital Expenditures | -15.28M |
| Free Cash Flow | 38.80M |
| FCF Per Share | 0.30 |
CI&T Inc operates with a gross margin of 31.41, reflecting its pricing power and cost economics. The operating margin of 11.99 and net profit margin of 7.90 provide insight into operational efficiency.
| Gross Margin | 31.41 |
| Operating Margin | 11.99 |
| Pretax Margin | 10.84 |
| Profit Margin | 7.90 |
| EBITDA Margin | 15.88 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 1.71 |
| FCF Yield | 2.00 |
CI&T Inc posts an Altman Z-Score of 12.48, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 12.48 |